BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 21449013)

  • 1. Parkinson's disease and pain--nondopaminergic mechanisms are likely to be important too.
    Lim SY; Farrell MJ; Evans AH
    Mov Disord; 2011 Jun; 26(7):1353-4. PubMed ID: 21449013
    [No Abstract]   [Full Text] [Related]  

  • 2. Response to heat pain stimulation in idiopathic Parkinson's disease.
    Nandhagopal R; Troiano AR; Mak E; Schulzer M; Bushnell MC; Stoessl AJ
    Pain Med; 2010 Jun; 11(6):834-40. PubMed ID: 20624238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Facilitated temporal summation of pain at spinal level in Parkinson's disease.
    Perrotta A; Sandrini G; Serrao M; Buscone S; Tassorelli C; Tinazzi M; Zangaglia R; Pacchetti C; Bartolo M; Pierelli F; Martignoni E
    Mov Disord; 2011 Feb; 26(3):442-8. PubMed ID: 21462260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Drug therapy in Parkinson's disease].
    van Hilten JJ; Roos RA
    Ned Tijdschr Geneeskd; 1999 Jan; 143(5):234-40. PubMed ID: 10086151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pain intensity on and off levodopa in patients with Parkinson's disease.
    Nebe A; Ebersbach G
    Mov Disord; 2009 Jun; 24(8):1233-7. PubMed ID: 19412949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine dysregulation syndrome in Parkinson's disease patients: from reward to penalty.
    Bonci A; Singh V
    Ann Neurol; 2006 May; 59(5):733-4. PubMed ID: 16634013
    [No Abstract]   [Full Text] [Related]  

  • 7. [Non-dopaminergic treatments for Parkinson's disease].
    Derkinderen P
    Rev Neurol (Paris); 2010 Oct; 166(10):811-5. PubMed ID: 20832090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parkinson's disease.
    Barboi AC; Goetz CG
    Clin Neuropharmacol; 1999; 22(4):184-91. PubMed ID: 10442246
    [No Abstract]   [Full Text] [Related]  

  • 9. Pain is common in Parkinson's disease.
    Hanagasi HA; Akat S; Gurvit H; Yazici J; Emre M
    Clin Neurol Neurosurg; 2011 Jan; 113(1):11-3. PubMed ID: 20800342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Disturbance of micturition in Parkinson's disease].
    Sakakibara R; Uchiyama T; Yoshiyama M; Hattori T
    No To Shinkei; 2001 Nov; 53(11):1009-14. PubMed ID: 11761908
    [No Abstract]   [Full Text] [Related]  

  • 11. Levodopa and the progression of Parkinson's disease.
    Walton-Hadlock JL
    N Engl J Med; 2005 Mar; 352(13):1386; author reply 1386. PubMed ID: 15800240
    [No Abstract]   [Full Text] [Related]  

  • 12. [Therapeutic strategies in Parkinson's disease].
    Shoulson I
    Arch Neurobiol (Madr); 1991; 54(6):277-81. PubMed ID: 1687429
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of levodopa on pain threshold in Parkinson's disease: a clinical and positron emission tomography study.
    Brefel-Courbon C; Payoux P; Thalamas C; Ory F; Quelven I; Chollet F; Montastruc JL; Rascol O
    Mov Disord; 2005 Dec; 20(12):1557-63. PubMed ID: 16078219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Parkinson's disease].
    Yokochi M
    Ryoikibetsu Shokogun Shirizu; 1999; (27 Pt 2):5-14. PubMed ID: 10434578
    [No Abstract]   [Full Text] [Related]  

  • 15. Levodopa therapeutics for Parkinson's disease: new developments.
    LeWitt PA
    Parkinsonism Relat Disord; 2009 Jan; 15 Suppl 1():S31-4. PubMed ID: 19131040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Objective assessment in Parkinson's disease: optoelectronic movement and force analysis in clinical routine and research.
    Ingvarsson PE; Johnels B; Steg G; Olsson T
    Adv Neurol; 1999; 80():447-58. PubMed ID: 10410755
    [No Abstract]   [Full Text] [Related]  

  • 17. The role of dopamine in cognitive sequence learning: evidence from Parkinson's disease.
    Shohamy D; Myers CE; Grossman S; Sage J; Gluck MA
    Behav Brain Res; 2005 Jan; 156(2):191-9. PubMed ID: 15582105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levodopa therapy for Parkinson's disease: challenges and future prospects.
    Olanow CW; Lees A; Obeso J
    Mov Disord; 2008; 23 Suppl 3():S495-6. PubMed ID: 18781670
    [No Abstract]   [Full Text] [Related]  

  • 19. Synaptic plasticity, dopamine and Parkinson's disease: one step ahead.
    Calabresi P; Mercuri NB; Di Filippo M
    Brain; 2009 Feb; 132(Pt 2):285-7. PubMed ID: 19168452
    [No Abstract]   [Full Text] [Related]  

  • 20. [Optimization of the treatment of Parkinson's disease using dopamine agonists].
    Rinne UK
    Arch Neurobiol (Madr); 1991; 54(6):282-7. PubMed ID: 1687430
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.